In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.
AIMS: The aim of this work was to use hyperpolarized carbon-13 ((13)C) magnetic resonance (MR) spectroscopy and cine MR imaging (MRI) to assess in vivo cardiac metabolism and function in the 15-week-old spontaneously hypertensive rat (SHR) heart. At this time point, the SHR displays hypertension and...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797068315304132608 |
|---|---|
| author | Dodd, M Ball, DR Schroeder, M Le Page, L Atherton, H Heather, L Seymour, A Ashrafian, H Watkins, H Clarke, K Tyler, D |
| author_facet | Dodd, M Ball, DR Schroeder, M Le Page, L Atherton, H Heather, L Seymour, A Ashrafian, H Watkins, H Clarke, K Tyler, D |
| author_sort | Dodd, M |
| collection | OXFORD |
| description | AIMS: The aim of this work was to use hyperpolarized carbon-13 ((13)C) magnetic resonance (MR) spectroscopy and cine MR imaging (MRI) to assess in vivo cardiac metabolism and function in the 15-week-old spontaneously hypertensive rat (SHR) heart. At this time point, the SHR displays hypertension and concentric hypertrophy. One of the cellular adaptations to hypertrophy is a reduction in β-oxidation, and it has previously been shown that in response to hypertrophy the SHR heart switches to a glycolytic/glucose-oxidative phenotype. METHODS AND RESULTS: Cine-MRI (magnetic resonance imaging) was used to assess cardiac function and degree of cardiac hypertrophy. Wistar rats were used as controls. SHRs displayed functional changes in stroke volume, heart rate, and late peak-diastolic filling alongside significant hypertrophy (a 56% increase in left ventricular mass). Using hyperpolarized [1-(13)C] and [2-(13)C]pyruvate, an 85% increase in (13)C label flux through pyruvate dehydrogenase (PDH) was seen in the SHR heart and (13)C label incorporation into citrate, acetylcarnitine, and glutamate pools was elevated in proportion to the increase in PDH flux. These findings were confirmed using biochemical analysis of PDH activity and protein expression of PDH regulatory enzymes. CONCLUSIONS: Functional and structural alterations in the SHR heart are consistent with the hypertrophied phenotype. Our in vivo work indicates a preference for glucose metabolism in the SHR heart, a move away from predominantly fatty acid oxidative metabolism. Interestingly, (13)C label flux into lactate was unchanged, indicating no switch to an anaerobic glycolytic phenotype, but rather an increased reliance on glucose oxidation in the SHR heart. |
| first_indexed | 2024-03-06T22:08:58Z |
| format | Journal article |
| id | oxford-uuid:5123bf9e-7a26-472f-b7ea-e1b66b70b15d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:08:58Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:5123bf9e-7a26-472f-b7ea-e1b66b70b15d2022-03-26T16:17:42ZIn vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5123bf9e-7a26-472f-b7ea-e1b66b70b15dEnglishSymplectic Elements at Oxford2012Dodd, MBall, DRSchroeder, MLe Page, LAtherton, HHeather, LSeymour, AAshrafian, HWatkins, HClarke, KTyler, DAIMS: The aim of this work was to use hyperpolarized carbon-13 ((13)C) magnetic resonance (MR) spectroscopy and cine MR imaging (MRI) to assess in vivo cardiac metabolism and function in the 15-week-old spontaneously hypertensive rat (SHR) heart. At this time point, the SHR displays hypertension and concentric hypertrophy. One of the cellular adaptations to hypertrophy is a reduction in β-oxidation, and it has previously been shown that in response to hypertrophy the SHR heart switches to a glycolytic/glucose-oxidative phenotype. METHODS AND RESULTS: Cine-MRI (magnetic resonance imaging) was used to assess cardiac function and degree of cardiac hypertrophy. Wistar rats were used as controls. SHRs displayed functional changes in stroke volume, heart rate, and late peak-diastolic filling alongside significant hypertrophy (a 56% increase in left ventricular mass). Using hyperpolarized [1-(13)C] and [2-(13)C]pyruvate, an 85% increase in (13)C label flux through pyruvate dehydrogenase (PDH) was seen in the SHR heart and (13)C label incorporation into citrate, acetylcarnitine, and glutamate pools was elevated in proportion to the increase in PDH flux. These findings were confirmed using biochemical analysis of PDH activity and protein expression of PDH regulatory enzymes. CONCLUSIONS: Functional and structural alterations in the SHR heart are consistent with the hypertrophied phenotype. Our in vivo work indicates a preference for glucose metabolism in the SHR heart, a move away from predominantly fatty acid oxidative metabolism. Interestingly, (13)C label flux into lactate was unchanged, indicating no switch to an anaerobic glycolytic phenotype, but rather an increased reliance on glucose oxidation in the SHR heart. |
| spellingShingle | Dodd, M Ball, DR Schroeder, M Le Page, L Atherton, H Heather, L Seymour, A Ashrafian, H Watkins, H Clarke, K Tyler, D In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title | In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title_full | In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title_fullStr | In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title_full_unstemmed | In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title_short | In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. |
| title_sort | in vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart |
| work_keys_str_mv | AT doddm invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT balldr invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT schroederm invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT lepagel invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT athertonh invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT heatherl invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT seymoura invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT ashrafianh invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT watkinsh invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT clarkek invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart AT tylerd invivoalterationsincardiacmetabolismandfunctioninthespontaneouslyhypertensiveratheart |